Merck Completes Acquisition of ArQule
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the successful completion…
Pharmaceuticals, Biotechnology and Life Sciences
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the successful completion…
STAMFORD, Conn.–(BUSINESS WIRE)–Adlon Therapeutics L.P. and Purdue Pharma L.P. will present data from three studies evaluating PRC-063 at the 2020…
Data to include outcomes from a Phase 3 Adult Laboratory Classroom study to evaluate the safety and efficacy of Adhansia…
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Ironshore Pharmaceuticals Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc. and a leader in…
Not for Distribution to U.S. Newswire Servicers or For Dissemination in the United States TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or…
Believes Alpha’s Contingency-Laden “Proposal” is a Blatant Attempt to Mislead Shareholders into Giving Alpha Control of OncoSec Before Alpha Makes…
DUBLIN–(BUSINESS WIRE)–The “Protein Phosphatase 2A (PP2A or EC 3.1.3.16) – Pipeline Review, H2 2019” drug pipelines has been added to…
DUBLIN–(BUSINESS WIRE)–The “Lymphocyte Activation Gene 3 Protein – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.…
AUXVASSE, Mo.–(BUSINESS WIRE)–#CRO–Sinclair Research, a leading provider of nonclinical contract research services, today announced an agreement to acquire the assets…
Complete Responses Noted in Multiple Tumor Types (including Pancreatic Cancer, Triple Negative Breast Cancer, Head and Neck Cancer, Merkel Cell…